OABI today
$4.93-$0.02 (-0.40%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourExpanding
15 minLeaning Bullish
5 minSymmetric Triangle
Daily trend turns up above $5.43
Key levels
Resistance$5.41
Resistance$5.00
Support$4.51
Support$4.12
Latest news & SEC filings
SEC FilingOmniAb, Inc. filed an insider trading report (Form 4)
NewsOmniAb reports reaching self-sustaining cash flow
EarningsOmniAb holds Q3 2026 earnings call
EarningsOmniAb Posts Q3 2026 Results, Notes Business Updates
All OABI news →About OmniAb
OmniAb provides antibody discovery capabilities to drugmakers and research organizations. Its offerings center on engineered animals, such as rats, chickens, mice, and cow-based platforms, that produce human-sequence antibodies, paired with screening methods and computational tools. Customers use these services to find therapeutic candidates for conditions including cancer, immune disorders, and neurological diseases. Revenue comes from licensing arrangements that may include access charges, research work, milestone payments, and sales royalties.
Based on the company's 10-K filed Mar 4, 2026.
Nasdaq · Healthcare
OmniAb, Inc. (OABI)
What Is the Price Target for OABI?
SEPT Low Target
$6.00
SEPT Mid Target
$11.00
SEPT High Target
$12.00
Analyst Consensus
$11.00
Is OABI a Buy or Sell Right Now?
Thesis
- •Revenue growing -29.3% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for OABI.
Start Free Trial →Is OABI Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$9.47
27
Moat Score
NONE
2/9
Piotroski Score
9.3
Altman Z-Score
What Is Smart Money Doing with OABI?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Love Steven | director | Buy | 13,334 | - | Nov 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →OABI Growth Story
Revenue YoY
-29.3%
3yr Revenue CAGR
-31.9%
EPS Growth YoY
6.56%
FCF Growth YoY
10.9%
Revenue Trend
ACCELERATING
Dark Pool Trades for OABI
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for OABI, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:38:35 | $4.95 | 1,700 | $$8K | SELL |
| 14:38:35 | $4.92 | 2,723 | $$13K | SELL |
| 14:38:35 | $4.92 | 1,700 | $$8K | SELL |
| 14:38:35 | $4.96 | 1,800 | $$9K | SELL |
| 21:00:32 | $5.10 | 4,900 | $$25K | BUY |
5 dark pool trades shown · $$64K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for OmniAb, Inc. (OABI) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →OABI — frequently asked questions
What is OABI stock price today?
OmniAb, Inc. (OABI) is at $4.93, down 0.40% (-$0.02) at the Nov 13, 2026 close.
Why is OABI stock moving today?
Latest OABI news — Nov 2, 2026: OmniAb, Inc. filed an insider trading report (Form 4) · Nov 1, 2026: OmniAb reports reaching self-sustaining cash flow
What is the OABI price target?
The average analyst price target for OABI is $11.00, ranging from $6 to $12, based on 3 analysts. Latest: Leerink Partners maintains on Oct 7, 2026.
What do analysts rate OABI?
Analyst ratings for OABI: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did OABI beat earnings?
OABI last reported on Oct 30, 2026: EPS -$0.12 vs -$0.13 expected — a beat of 5.6%.
Does OABI pay a dividend?
OABI does not currently pay a dividend.
What are OABI support and resistance levels?
Support: $4.51, $4.12. Resistance: $5.00, $5.41.
What are insiders doing with OABI?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on OABI?
Nov 2, 2026: OmniAb, Inc. filed an insider trading report (Form 4) · Nov 1, 2026: OmniAb reports reaching self-sustaining cash flow · Oct 30, 2026: OmniAb holds Q3 2026 earnings call